| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.03 | 0.5 |